factor IX

(redirected from BeneFix)
Also found in: Dictionary, Thesaurus, Medical.

factor IX

[′fak·tər ′nīn]
(biochemistry)
References in periodicals archive ?
Pfizer and Takeda will work closely to smoothly implement the marketing transfer of PREVENAR13 and BENEFIX.
The two-period Phase III trial included six months of on-demand therapy only, followed by 12 months of routine prophylaxis with BeneFIX 100 IU/kg once-weekly.
Chief executive Mr Ian Harvey said yesterday that he expected to see continued strong growth from BeneFIX, a treatment for haemophilia B.
Its products include Lyrica, the Prevnar family of products, Enbrel, Celebrex, Lipitor, Viagra, Zyvox, Sutent, EpiPen, Toviaz, Tygacil, Rapamune, Xalkori, Inlyta, Norvasc, BeneFIX, Genotropin and Enbrel, among others.
26 Tysabri Biogen IDEC 27 Kogenate FS/ Bayer Helixate FS 28 NovoSeven Novo Nordisk 29 Soliris Alexion 30 Neupogen Amgen 31 Simponi J&J 32 Xolair Roche Genentech & Novartis 33 Stelara J&J 34 Betaseron Bayer 35 Orencia BMS 36 Infanrix GSK 37 Humulin Lilly and Roche 38 Actemra Roche 39 Forteo Lilly 40 Nordi tropin Novo Nordisk 41 Synagis AstraZeneca 42 Yervoy BMS 43 Cerezyme Genzyme 44 BeneFIX Pfizer 45 Cimzia UCB Group 46 Gonal-f Merck KGaA 47 Fluzone Sanofi 48 TNKase Roche Genentech 49 Genotropin Pfizer 50 Xgeva Amgen 51 Lumizyme/ Myozyme Genzyme 52 Synflorix GSK 53 Pulmozyme Roche Genentech 54 Zostavax Merck & Co.
For hemophilia B, the most widely used branded drug is BeneFIX, a clotting factor from Pfizer Inc.
3,737 2% Prevnar 13 pneumococcal vaccine $3,718 2% Celebrex arthritis $2,719 8% Viagra erectile dysfunction $2,051 4% Norvasc antihypertensive $1,349 -7% Zyvox bacterial infections $1,345 5% Sutent cancer $1,236 4% Premarin menopause $1,073 6% Genotropin HGH deficiency $832 -6% Xalatan glaucoma $806 -36% Benefix hemophilia $775 12% Detrol overactive bladder $761 -14% Vfend fungal infections $754 1% Chantix smoking cessation $670 -7% Pristiq neuropathic pain $630 9% ReFacto AF hemophilia $584 15% Zoloft antidepressant $541 -6% Revatio pulmonary arterial hypertension $534 0% Medrol inflammation $523 3% Alliance Revenues * $3.
The main purpose of the Panel was to probe new developments on extended half-life (EHL) products, new products for inhibitor formation and new competitors to BeneFIX and NovoSeven.